Your browser doesn't support javascript.
loading
Novel Anti-HER2 Antibody-Drug Conjugates Versus T-DM1 for HER2-Positive Metastatic Breast Cancer After Tyrosine Kinase Inhibitors Treatment.
Ji, Chenchen; Li, Feng; Yuan, Yang; Zhang, Huiqiang; Bian, Li; Zhang, Shaohua; Wang, Tao; Li, Jianbin; Jiang, Zefei.
Afiliación
  • Ji C; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Li F; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Yuan Y; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Zhang H; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Bian L; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Zhang S; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Wang T; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Li J; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Jiang Z; Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People's Republic of China.
Oncologist ; 28(10): e859-e866, 2023 10 03.
Article en En | MEDLINE | ID: mdl-37218076

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inmunoconjugados / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inmunoconjugados / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article